Status:
RECRUITING
Developing Trustworthy Artificial Intelligence (AI)-Driven Tools to Predict Vascular Disease Risk and Progression
Lead Sponsor:
Amsterdam UMC, location VUmc
Collaborating Sponsors:
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Technical University of Twente
Conditions:
Aneurysm Abdominal
Peripheral Arterial Disease
Eligibility:
All Genders
40-90 years
Brief Summary
The VASCULAID-RETRO study, within the broader VASCULAID project, aims to create artificial intelligence (AI) algorithms that can predict cardiovascular events and the progression of abdominal aortic a...
Detailed Description
To date, it is unknown which abdominal aortic aneurysm (AAA) and peripheral arterial disease (PAD) patients will suffer cardiovascular events or in which patients the AAA or PAD will progress. In the ...
Eligibility Criteria
Inclusion
- Males and females, 40-90 years old, with an AAA \>3cm. This includes patients with infrarenal, juxtarenal, suprarenal, iliac (defined as 1.5x its normal diameter) aneurysms, as well as mycotic aneurysms. Patients that have had interventions or ruptures will also be included
- Males and females, 40-90 years old, all PAD patients (Fontaine stages 1,2,3, and 4).
Exclusion
- Patients with an ascending, thoracic, thoracoabdominal (type 1-3) aneurysm.
Key Trial Info
Start Date :
October 31 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2029
Estimated Enrollment :
11000 Patients enrolled
Trial Details
Trial ID
NCT06206369
Start Date
October 31 2023
End Date
May 1 2029
Last Update
January 16 2024
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital District of Helsinki and Uusimaa (HUS)
Helsinki, Finland
2
Asklepios kliniken hamburg
Hamburg, Germany
3
Amsterdam UMC
Amsterdam, Netherlands
4
University Hospital Center of São João
Porto, Portugal